1LCL
CHARCOT-LEYDEN CRYSTAL PROTEIN
Summary for 1LCL
| Entry DOI | 10.2210/pdb1lcl/pdb |
| Descriptor | LYSOPHOSPHOLIPASE (2 entities in total) |
| Functional Keywords | charcot-leyden crystal protein, serine esterase |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasmic granule: Q05315 |
| Total number of polymer chains | 1 |
| Total formula weight | 16499.89 |
| Authors | Acharya, K.R.,Leonidas, D.D. (deposition date: 1996-01-18, release date: 1997-01-11, Last modification date: 2024-02-14) |
| Primary citation | Leonidas, D.D.,Elbert, B.L.,Zhou, Z.,Leffler, H.,Ackerman, S.J.,Acharya, K.R. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure, 3:1379-1393, 1995 Cited by PubMed Abstract: The Charcot-Leyden crystal (CLC) protein is a major autocrystallizing constituent of human eosinophils and basophils, comprising approximately 10% of the total cellular protein in these granulocytes. Identification of the distinctive hexagonal bipyramidal crystals of CLC protein in body fluids and secretions has long been considered a hallmark of eosinophil-associated allergic inflammation. Although CLC protein possesses lysophospholipase activity, its role(s) in eosinophil or basophil function or associated inflammatory responses has remained speculative. PubMed: 8747464DOI: 10.1016/S0969-2126(01)00275-1 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report






